Cointime

Azellon Cell Therapeutics

company

About

Azellon Cell Therapeutics is focused on developing stem cell therapy for the repair of avascular meniscal tears.

  • 1 - 10

Highlights

Total Funding Amount
£1.60M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Seed
Last Funding Money Raised
£1.60M
Industries
Biotechnology,Therapeutics
Founded date
Jan 1, 2007
Number Of Employee
1 - 10
Operating Status
Active

Azellon is focused on developing stem cell therapy for the repair of avascular meniscal tears. Today orthopaedic surgeons are partially or fully removing the meniscus which over 4-6 years will lead to osteoarthritic changes in the knee joint. The technology behind Azellon was developed by Professor Anthony Hollander over the last 5 years and has already been proven highly successful in an in-vitro model.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
£1.60M
Azellon Cell Therapeutics has raised a total of £1.60M in funding over 2 rounds. Their latest funding was raised on Apr 20, 2009 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 20, 2009 Seed £1.60M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Azellon Cell Therapeutics is funded by 1 investors. Wyvern Seed Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Wyvern Seed Fund — Seed
Cointime
เนื้อหา
บริษัท